Peak Bio, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Peak Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • Peak Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.49M, a 26.5% increase year-over-year.
  • Peak Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.23M, a 63.6% increase year-over-year.
  • Peak Bio, Inc. annual Operating Income (Loss) for 2023 was -$13.1M, a 10.3% decline from 2022.
  • Peak Bio, Inc. annual Operating Income (Loss) for 2022 was -$11.8M, a 30.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13.1M -$1.22M -10.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-08-06
2022 -$11.8M -$2.78M -30.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-08-06
2021 -$9.07M Jan 1, 2021 Dec 31, 2021 10-K 2023-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.